InvestorsHub Logo
icon url

akblack

09/16/20 3:50 AM

#20696 RE: ratna1 #20695

In most areas, agreed, however it is a highly US-centric point of view... thinking that FDA is its only real chance of success. The FDA only represents the US market. There are dozens of other major markets where this drug is in high demand and emergency use already (India, Israel and Brazil just to name a few), none of which require US FDA approval for anything they offer their citizens. Therefore, this company's potential for success is even higher than most people with a US POV are realising. America is not the whole world. Relief isn't even American, its Swiss, with quick access to major European and Middle Eastern markets without as much red tape as in the US. I would simply suggest for investors, especially those in / from the US, to keep these facts in mind as well - the world is much bigger than 'merica.